EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential Cardioprotective Effect of a GRK5 Inhibitor Against NF-κB-Mediated Inflammation in an Animal Model of Isoproterenol-Induced Myocardial Infarction

Asma S Alonazi iD, Anfal F Bin Dayel iD, Bashayer A Alkhathlan iD, Lulu M Alkaff, Ahad T Alrashed, Reema A Bin Klaib, Doaa M Elnagar, Maha A Alamin iD, Rehab A Ali, Alaa Alnoor Alameen iD, Nouf M Alrasheed iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Asma S Alonazi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: G-Protein-Coupled Receptor Kinase 5, Myocardial Infarction, NF-kappa B, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia., King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI) is a pathological condition associated with various cardiovascular diseases and leads to heart failure. Nuclear factor-kappa B (NF-κB) is upregulated in the infarcted heart. G protein-coupled receptor kinase 5 (GRK5) also plays a complex role in both tissue repair and maladaptive hypertrophy in cardiovascular diseases; however, its effect on NF-κB-mediated inflammation has not yet been elucidated. Thus, this study aims to investigate the effects of Amlexanox (AMX), a potential GRK5 inhibitor, in an animal model of MI by assessing its impact on GRK5-mediated NF-κB/inflammatory processes. Thirty-two male mice were randomly allocated into four groups: control, MI, (MI treated with vehicle (MI + V), and MI + AMX (AMX: 2.5 mg/100 g/day). MI was induced using ISO on days 21 and 22. The cardioprotective impacts of Amlexanox were verified by evaluating cardiac injury, inflammatory biomarker concentrations, and histopathological alterations in cardiomyocytes. MI induction was confirmed by increases in heart weight/body weight ratio (HW/BW) (p < 0.001), troponin (p < 0.001), creatine kinase (p < 0.001), and LDH (p < 0.001). Treatment with AMX resulted in a significant reduction in cardiac injury biomarkers (p < 0.001) and IL-6 (p < 0.05). The protein level of NF-κB(p65) and NF-κB(p105) was significantly increased in cardiac myocytes of the MI group. Treatment with AMX led to a significant decrease in NF-κB(p65) and (p105) expression (p < 0.01 and p < 0.001, respectively), and GRK5 and MEF2α protein levels were also upregulated. In conclusion, AMX shows potential cardioprotective effects by modulating the GRK5/MEF2-mediated NF-κB inflammatory signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-Protein-Coupled Receptor Kinase 5Myocardial InfarctionNF-kappa BInflammationCardiotonic AgentsAnimalsMaleDisease Models, AnimalMiceIsoproterenolMyocytes, CardiacInterleukin-6Signal TransductionAminopyridines

Stichwörter der Autor:innen

AmlexanoxGRK5NF-κBinflammationmyocardial infarction

Substanzen

G-Protein-Coupled Receptor Kinase 5NF-kappa BCardiotonic AgentsIsoproterenolGrk5 protein, mouseamlexanoxInterleukin-6Aminopyridines

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Asma S Alonazi, Anfal F Bin Dayel, Bashayer A Alkhathlan, Maha A Alamin, Alaa Alnoor Alameen, Nouf M Alrasheed

Förderung

  • Ongoing Research Funding Program, King Saud University, Riyadh, Saudi Arabia.
  • King Saud University

Zitieren

APA

Alonazi, A. S., Bin Dayel, A. F., Alkhathlan, B. A., Alkaff, L. M., Alrashed, A. T., Bin Klaib, R. A., Elnagar, D. M., Alamin, M. A., Ali, R. A., Alameen, A. A., & Alrasheed, N. M. (2025). Potential Cardioprotective Effect of a GRK5 Inhibitor Against NF-κB-Mediated Inflammation in an Animal Model of Isoproterenol-Induced Myocardial Infarction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010053

Vancouver

Alonazi AS, Bin Dayel AF, Alkhathlan BA, Alkaff LM, Alrashed AT, Bin Klaib RA, et al. Potential Cardioprotective Effect of a GRK5 Inhibitor Against NF-κB-Mediated Inflammation in an Animal Model of Isoproterenol-Induced Myocardial Infarction. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010053

BibTeX
@article{Alonazi2025,
  author = {Alonazi, Asma S and Bin Dayel, Anfal F and Alkhathlan, Bashayer A and Alkaff, Lulu M and Alrashed, Ahad T and Bin Klaib, Reema A and Elnagar, Doaa M and Alamin, Maha A and Ali, Rehab A and Alameen, Alaa Alnoor and Alrasheed, Nouf M},
  title = {Potential Cardioprotective Effect of a GRK5 Inhibitor Against NF-κB-Mediated Inflammation in an Animal Model of Isoproterenol-Induced Myocardial Infarction},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010053}
}
Kostenlos starten →